Browsing by Subject "high-impact chronic pain"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Item Open Access High-impact chronic pain transition in surgical recipients with cervical spondylotic myelopathy.(Journal of neurosurgery. Spine, 2022-01) Cook, Chad E; George, Steven Z; Asher, Anthony L; Bisson, Erica F; Buchholz, Avery L; Bydon, Mohamad; Chan, Andrew K; Haid, Regis W; Mummaneni, Praveen V; Park, Paul; Shaffrey, Christopher I; Than, Khoi D; Tumialan, Luis M; Wang, Michael Y; Gottfried, Oren NObjective
High-impact chronic pain (HICP) is a recently proposed metric that indicates the presence of a severe and troubling pain-related condition. Surgery for cervical spondylotic myelopathy (CSM) is designed to halt disease transition independent of chronic pain status. To date, the prevalence of HICP in individuals with CSM and their HICP transition from presurgery is unexplored. The authors sought to define HICP prevalence, transition, and outcomes in patients with CSM who underwent surgery and identify predictors of these HICP transition groups.Methods
CSM surgical recipients were categorized as HICP at presurgery and 3 months if they exhibited pain that lasted 6-12 months or longer with at least one major activity restriction. HICP transition groups were categorized and evaluated for outcomes. Multivariate multinomial modeling was used to predict HICP transition categorization.Results
A majority (56.1%) of individuals exhibited HICP preoperatively; this value declined to 15.9% at 3 months (71.6% reduction). The presence of HICP was also reflective of other self-reported outcomes at 3 and 12 months, as most demonstrated notable improvement. Higher severity in all categories of self-reported outcomes was related to a continued HICP condition at 3 months. Both social and biological factors predicted HICP translation, with social factors being predominant in transitioning to HICP (from none preoperatively).Conclusions
Many individuals who received CSM surgery changed HICP status at 3 months. In a surgical population where decisions are based on disease progression, most of the changed status went from HICP preoperatively to none at 3 months. Both social and biological risk factors predicted HICP transition assignment.